Search

Your search keyword '"Maiques-Diaz A"' showing total 132 results

Search Constraints

Start Over You searched for: Author "Maiques-Diaz A" Remove constraint Author: "Maiques-Diaz A"
132 results on '"Maiques-Diaz A"'

Search Results

2. An atlas of cells in the human tonsil

3. Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies

5. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape

6. S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY

8. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape

12. Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia

13. S142: FOXO1-RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY

15. FOXO1‐RICTOR AXIS INDUCES AKT PHOSPHORYLATION DURING CLL CELL ADAPTATION TO BCR INHIBITORS: IMPLICATIONS FOR COMBINATORIAL THERAPY

16. HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block

17. Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells

18. LSD1 inhibitors disrupt the GFI1 transcription repressor complex

19. Development of a Novel Chromatin Activation Score As a Powerful Independent Prognostic Factor in Chronic Lymphocytic Leukemia

20. Therapeutic Targeting of EP300/CBP By Bromodomain Inhibition in Acute Myeloid Leukemia

23. Therapeutic Targeting of EP300/CBP By Bromodomain Inhibition in Acute Myeloid Leukemia

29. NOTCH1 drives immune-escape mechanisms in B cell malignancies

32. NOTCH1 drives immune-escape mechanisms in B cell malignancies

33. Abrogation of RUNX1 gene expression in de novo myelodysplastic syndrome with t(4;21)(q21;q22)

34. Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia

37. Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1

38. Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia

39. LSD1: biologic roles and therapeutic targeting

40. Effect of the COVID-19 Pandemic on Laboratory and Clinical Research: A Testimony and a Call to Action From Researchers

42. MAPK8-mediated stabilization of SP1 is essential for RUNX1-RUNX1T1 - driven leukaemia

43. Abstracts from the 4th World Congress of the International Dermoscopy Society, April 16-18, 2015, Vienna, Austria

45. Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1

46. The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia

48. LSD1 inhibitors disrupt the GFI1 transcription repressor complex

49. Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1

Catalog

Books, media, physical & digital resources